• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生物安全二级实验室管理中的SINS模型:探索与实践

SINS model in the management of biosafety level 2 laboratories: exploration and practice.

作者信息

Qiu Xiaoxia, Weng Jingqing, Jiang Zhenggang, Yan Congcong, Gu Hua

机构信息

Zhejiang Provincial Center for Medical Science Technology & Education, Hangzhou 310000, China.

Provincial Center for Disease Control and Prevention, Hangzhou 310000, China.

出版信息

Biosaf Health. 2019 Dec;1(3):129-133. doi: 10.1016/j.bsheal.2019.12.004. Epub 2019 Dec 17.

DOI:10.1016/j.bsheal.2019.12.004
PMID:32501445
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7148668/
Abstract

A significant number of biosafety level 2 (BSL-2) laboratories have been established in many countries for studies of various types of pathogenic agents and other infectious biological materials. The harmonized management of biological risks in such diverse laboratories thus appears as a real challenge. Zhejiang Province in China has taken the initiative to establish a comprehensively integrated laboratory biosafety management system called SINS (Standardization, Informatization, Normalization and Systematization). The SINS model system has been introduced and adopted in 1,721 BSL-2 laboratories in Zhejiang Province, and thus lead to an increase in the number of biosafety committees from 20% to more than 95% from 2007 to 2018, and the number of biosafety laboratory managers who knows biosafety-related laws and regulations increase from 52.7% to 83.7% from 2009 to 2017. Such achievements indicate that the successful implementation of SINS model has increased the effective control of biological risks in BSL-2 laboratories of the Zhejiang Province. SINS model and its main effects on leading the improvement of laboratory biosafety management was presented in this review. The SINS model helps to strengthen laboratory biosafety and thus effectively reduces occurrence of biosafety-related incidences. This model can potentially be used by other regions or countries where harmonized biosafety management system is still under-developing.

摘要

许多国家已经建立了大量的生物安全二级(BSL-2)实验室,用于研究各类病原体和其他传染性生物材料。因此,对这些多样化实验室的生物风险进行统一管理成为一项切实的挑战。中国浙江省率先建立了一个名为SINS(标准化、信息化、规范化和系统化)的全面综合实验室生物安全管理体系。SINS模型系统已在浙江省的1721个BSL-2实验室中引入并采用,从而使生物安全委员会的数量从2007年到2018年从20%增加到95%以上,并且了解生物安全相关法律法规的生物安全实验室管理人员数量从2009年到2017年从52.7%增加到83.7%。这些成果表明,SINS模型的成功实施增强了浙江省BSL-2实验室对生物风险的有效控制。本综述介绍了SINS模型及其在引领实验室生物安全管理改进方面的主要成效。SINS模型有助于加强实验室生物安全,从而有效减少生物安全相关事件的发生。该模型有可能被其他仍在发展统一生物安全管理体系的地区或国家所采用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5419/7148668/9d7661998b25/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5419/7148668/9c28c67bebd3/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5419/7148668/9d7661998b25/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5419/7148668/9c28c67bebd3/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5419/7148668/9d7661998b25/gr2.jpg

相似文献

1
SINS model in the management of biosafety level 2 laboratories: exploration and practice.生物安全二级实验室管理中的SINS模型:探索与实践
Biosaf Health. 2019 Dec;1(3):129-133. doi: 10.1016/j.bsheal.2019.12.004. Epub 2019 Dec 17.
2
Current status and future challenges of high-level biosafety laboratories in China.中国高级别生物安全实验室的现状与未来挑战
J Biosaf Biosecur. 2019 Sep;1(2):123-127. doi: 10.1016/j.jobb.2019.09.005. Epub 2019 Oct 24.
3
Biosafety Training and Incident-reporting Practices in the United States: A 2008 Survey of Biosafety Professionals.美国的生物安全培训与事故报告实践:2008年生物安全专业人员调查
Appl Biosaf. 2009;14(3):135-143. doi: 10.1177/153567600901400305.
4
The state of biosafety across China's CDC microbiology laboratories: insights from a nationwide survey (2021-2023).中国疾病预防控制中心微生物学实验室生物安全状况:全国调查的见解(2021-2023 年)。
Front Public Health. 2024 Aug 2;12:1436503. doi: 10.3389/fpubh.2024.1436503. eCollection 2024.
5
Environmental Risk and Assessment Management System of High-level Biosafety Laboratory.高等级生物安全实验室环境风险与评估管理系统
Procedia Environ Sci. 2011;10:1193-1198. doi: 10.1016/j.proenv.2011.09.191. Epub 2011 Dec 20.
6
Certification & validation of biosafety level-2 & biosafety level-3 laboratories in Indian settings & common issues.印度生物安全二级和三级实验室的认证和验证及常见问题。
Indian J Med Res. 2017 Oct;146(4):459-467. doi: 10.4103/ijmr.IJMR_974_16.
7
Biosafety and Biosecurity in European Containment Level 3 Laboratories: Focus on French Recent Progress and Essential Requirements.欧洲3级生物安全实验室的生物安全与生物安保:聚焦法国近期进展及基本要求
Front Public Health. 2017 May 31;5:121. doi: 10.3389/fpubh.2017.00121. eCollection 2017.
8
Enhancing laboratory biosafety management: a comprehensive strategy from theory to practice.加强实验室生物安全管理:从理论到实践的综合策略。
Front Public Health. 2024 Sep 20;12:1439051. doi: 10.3389/fpubh.2024.1439051. eCollection 2024.
9
Management System Approach for Addressing Biosafety and Biosecurity of Emerging Pathogens in a Biosafety Level-3 Core Facility.生物安全3级核心设施中应对新出现病原体生物安全和生物安保的管理体系方法
Appl Biosaf. 2021 Dec 1;26(4):210-220. doi: 10.1089/apb.2021.0007. Epub 2021 Nov 24.
10
Safety Precautions and Operating Procedures in an (A)BSL-4 Laboratory: 1. Biosafety Level 4 Suit Laboratory Suite Entry and Exit Procedures.(A)BSL-4实验室的安全预防措施及操作程序:1. 生物安全4级防护服实验室套间的进出程序。
J Vis Exp. 2016 Oct 3(116):52317. doi: 10.3791/52317.

引用本文的文献

1
Clinical Application of Antibody Immunity Against SARS-CoV-2: Comprehensive Review on Immunoassay and Immunotherapy.新型冠状病毒抗体免疫的临床应用:免疫测定法和免疫疗法的综合评价。
Clin Rev Allergy Immunol. 2023 Feb;64(1):17-32. doi: 10.1007/s12016-021-08912-y. Epub 2022 Jan 15.

本文引用的文献

1
Laboratory biosafety for handling emerging viruses.处理新出现病毒的实验室生物安全。
Asian Pac J Trop Biomed. 2017 May;7(5):483-491. doi: 10.1016/j.apjtb.2017.01.020. Epub 2017 Jan 7.
2
Standardized focus assay protocol for biosafety level four viruses.标准化四级生物安全病毒焦点测定协议。
J Virol Methods. 2019 Feb;264:51-54. doi: 10.1016/j.jviromet.2018.12.002. Epub 2018 Dec 1.
3
A Curriculum-Based Approach to Teaching Biosafety Through eLearning.一种通过电子学习进行生物安全教学的基于课程的方法。
Front Bioeng Biotechnol. 2018 Apr 10;6:42. doi: 10.3389/fbioe.2018.00042. eCollection 2018.
4
Laboratory Focus on Improving the Culture of Biosafety: Statewide Risk Assessment of Clinical Laboratories That Process Specimens for Microbiologic Analysis.实验室专注于改善生物安全文化:对处理微生物分析标本的临床实验室进行全州范围的风险评估。
J Clin Microbiol. 2017 Dec 26;56(1). doi: 10.1128/JCM.01569-17. Print 2018 Jan.
5
US State-Level Policy Responses to the Ebola Outbreak, 2014-2015.2014 - 2015年美国各州对埃博拉疫情的政策应对措施
J Public Health Manag Pract. 2017 Jan/Feb;23(1):11-19. doi: 10.1097/PHH.0000000000000384.
6
Middle East respiratory syndrome (MERS): a new zoonotic viral pneumonia.中东呼吸综合征(MERS):一种新的人畜共患病毒性肺炎。
Virulence. 2014 Aug 15;5(6):650-4. doi: 10.4161/viru.32077. Epub 2014 Aug 4.
7
Epidemiology of the avian influenza A (H7N9) outbreak in Zhejiang Province, China.中国浙江省人感染 H7N9 禽流感疫情流行病学特征。
BMC Infect Dis. 2014 May 8;14:244. doi: 10.1186/1471-2334-14-244.
8
From SARS to H7N9: the mechanism of responding to emerging communicable diseases has made great progress in China.从 SARS 到 H7N9:中国应对新发传染病的机制取得了重大进展。
Biosci Trends. 2013 Dec;7(6):290-3.
9
Fever with thrombocytopenia associated with a novel bunyavirus in China.中国发现一种新型布尼亚病毒所致发热伴血小板减少综合征
N Engl J Med. 2011 Apr 21;364(16):1523-32. doi: 10.1056/NEJMoa1010095. Epub 2011 Mar 16.
10
Framework for leadership and training of Biosafety Level 4 laboratory workers.生物安全四级实验室工作人员的领导与培训框架
Emerg Infect Dis. 2008 Nov;14(11):1685-8. doi: 10.3201/eid1411.080741.